DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
NCT05671887 is an observational study sponsored by Northwestern University. As of 21 Nov 2026, it is recruiting participants. It studies Bilateral Cancer, Lung Cancer and 1 more condition. The registry lists an enrollment of 125 participants at 1 site in 1 country. The registry lists a start date of 16 Nov 2022 and a primary completion date of 30 Nov 2032.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05671887 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | Northwestern University |
| Enrollment | 125 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Bilateral Cancer, Lung Cancer and Lung Transplant |
| Start | 16 Nov 2022 |
| Primary completion | 30 Nov 2032 |
| Study completion | 30 Nov 2032 |
| Last update posted | 21 Oct 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ankit Bharat, MD
Northwestern University
Principal Investigator - Rade Tomic, MD
Northwestern University
Principal Investigator - Young Chae, MD MPH MBA
Northwestern University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Thoracic Surgery, Canning Thoracic Institute (northwestern Memorial Hospital)
Chicago
Ankit Bharat, MDRade Tomic, MDYoung Chae, MD MPH MBARecruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05671887
Each answer restates registry values shown on this page.
What is NCT05671887?
NCT05671887 is an observational study sponsored by Northwestern University. It studies Bilateral Cancer, Lung Cancer and 1 more condition.
Is NCT05671887 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT05671887?
The registry names Ankit Bharat, MD (principal investigator, Northwestern University), Rade Tomic, MD (principal investigator, Northwestern University) and Young Chae, MD MPH MBA (principal investigator, Northwestern University) as overall officials.
Where does NCT05671887 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT05671887 expected to complete?
The registry lists a primary completion date of 30 Nov 2032 and a study completion date of 30 Nov 2032. The sponsor last updated the record on 21 Oct 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.